Megafine Pharma (P) is an API manufacturer based in India. It holds 26 active US drug master files across a filed portfolio of 27 molecules. Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 12 May 2023 as VAI. Customs aggregates show $245K of exports covering 3 molecules to 2 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| vapi 396 195valsad, India | Not on file |
| Vapi, India | Not on file |
| Vapi, India | 3006688078 |
| Nashik, India | 3005694111 |
| Molecule | Regulators | Docs |
|---|---|---|
| Bosentan | SFDA (Saudi Arabia), US FDA | 3 |
| Mirtazapine | SFDA (Saudi Arabia), US FDA | 3 |
| Solifenacin Succinate | SFDA (Saudi Arabia), US FDA | 3 |
| Cinacalcet | SFDA (Saudi Arabia), US FDA | 2 |
| Donepezil | SFDA (Saudi Arabia), US FDA | 2 |
| Memantine | SFDA (Saudi Arabia), US FDA | 2 |
| Rivaroxaban | SFDA (Saudi Arabia), US FDA | 2 |
| Teriflunomide | SFDA (Saudi Arabia), US FDA | 2 |
| Venlafaxine | US FDA | 2 |
| Ambrisentan | US FDA | 1 |
| Apixaban | US FDA | 1 |
| Apremilast | US FDA | 1 |
| Asenapine | US FDA | 1 |
| Betahistine Dihydrochloride | SFDA (Saudi Arabia) | 1 |
| Darifenacin | US FDA | 1 |
| Desvenlafaxine | US FDA | 1 |
| Edoxaban | US FDA | 1 |
| Lurasidone | US FDA | 1 |
| Mirabegron | US FDA | 1 |
| Paliperidone | US FDA | 1 |
| Prasugrel | US FDA | 1 |
| Pyrantel | US FDA | 1 |
| Quetiapine | US FDA | 1 |
| Tamsulosin | SFDA (Saudi Arabia) | 1 |
| Vildagliptin | SFDA (Saudi Arabia) | 1 |
| Vortioxetine | US FDA | 1 |
| Ziprasidone | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | None | 2 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $245K | 2 |
| 2024 | Not reported | $77K | 2 |
| 2023 | Not reported | $1.7M | 1 |
| 2022 | Not reported | $563K | 3 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Megafine Pharma (P) comes back tiered against every other supplier able to file there.
Start for free